Correlation Between Ziff Davis and Orchestra BioMed

Can any of the company-specific risk be diversified away by investing in both Ziff Davis and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ziff Davis and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ziff Davis and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Ziff Davis and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ziff Davis with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ziff Davis and Orchestra BioMed.

Diversification Opportunities for Ziff Davis and Orchestra BioMed

0.27

Correlation Coefficient

Ziff Davis  Orchestra BioMed

Modest diversification

The 3 months correlation between Ziff and Orchestra is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Ziff Davis and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Ziff Davis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ziff Davis are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Ziff Davis i.e., Ziff Davis and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Ziff Davis and Orchestra BioMed

Allowing for the 90-day total investment horizon Ziff Davis is expected to generate 0.57 times more return on investment than Orchestra BioMed. However, Ziff Davis is 1.76 times less risky than Orchestra BioMed. It trades about 0.14 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about 0.0 per unit of risk. If you would invest  4,764  in Ziff Davis on September 4, 2024 and sell it today you would earn a total of  1,178  from holding Ziff Davis or generate 24.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ziff Davis  vs.  Orchestra BioMed Holdings

Ziff Davis

Risk-Adjusted Performance

10 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ziff Davis are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile fundamental indicators, Ziff Davis exhibited solid returns over the last few months and may actually be approaching a breakup point.

Orchestra BioMed Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Orchestra BioMed is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Ziff Davis and Orchestra BioMed

The main advantage of trading using opposite Ziff Davis and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ziff Davis position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.

The idea behind Ziff Davis and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.